OraSure Technologies to Present at Thomas Weisel Partners' Growth Forum 6.0 Conference

BETHLEHEM, Pa.--(BUSINESS WIRE)--June 8, 2004--OraSure Technologies, Inc. (Nasdaq NM:OSUR) today announced that Mike Gausling, President and Chief Executive Officer, and Ron Spair, Executive Vice President and Chief Financial Officer, will speak to the investment community at the Thomas Weisel Partners' Growth Forum 6.0 Conference in Laguna Beach, California, at approximately 6:30 pm Eastern Time (3:30 pm Pacific Time) on June 15, 2004. The conference will be simultaneously webcast over the Internet.

Interested investors can access the live audio webcast of the discussion by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the audio webcast will be available until June 22, 2004, on OraSure Technologies' web site.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices and tests and other diagnostic products using its proprietary technologies, including immunoassays and other in vitro diagnostic tests and other medical devices. These products are sold in the United States and certain foreign countries to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. For more information on the Company, please visit www.orasure.com.

CONTACT:
OraSure Technologies, Inc.
Ronald H. Spair, 610-882-1820
Investorinfo@orasure.com
www.orasure.com